Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Feb 15, 2017, 13:29 ET Hospital Readmissions Reduced Significantly Using a Novel Heart Failure Protocol at New York City Nursing Homes

A novel protocol that remotely monitors congestive heart failure patients in skilled nursing facilities and uses automated alerts to notify...


Feb 15, 2017, 13:11 ET Autism Center at Rush Seeking Participants for Social Skills Study

Chicagoland families and providers with children on the autism spectrum are invited to enroll in a groundbreaking social skills study. The Autism...


Feb 15, 2017, 13:00 ET Sanaria's PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria in Clinical Trial

In a report published today in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the...


Feb 15, 2017, 11:01 ET Biosensors gibt Aufnahme des ersten Patienten in die US-amerikanische Schlüsselstudie BioFreedom "LEADERS FREE II" bekannt

Biosensors International Group, Ltd. ("Biosensors" oder das "Unternehmen"), ein Entwickler, Hersteller und Vermarkter innovativer medizinischer...


Feb 15, 2017, 10:42 ET FDA Approval Granted for BIOTRONIK's Ultra-Thin PRO-Kinetic Energy Cobalt Chromium Coronary Stent System

PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from BIOTRONIK gained FDA approval utilizing results from the BIOHELIX-I clinical...


Feb 15, 2017, 10:35 ET Blue Horizon International team to attend Clinical Trials Masterclass in New York

Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February...


Feb 15, 2017, 09:45 ET Biosensors anuncia reclutamiento del primer paciente en el nuevo ensayo BioFreedom en EE.UU. - "LEADERS FREE II"

Biosensors International Group, Ltd. ("Biosensors" o la "Compañía"), un desarrollador, fabricante y comercializador de innovadores dispositivos...


Feb 15, 2017, 09:15 ET TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review

TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based...


Feb 15, 2017, 09:04 ET BERG Initiates Phase I/II Monotherapy Trial of BPM 31510-IV in Patients with Glioblastoma Multiforme (GBM)

BERG LLC, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Feb 15, 2017, 09:00 ET Medical Marijuana, Inc. Subsidiary, HempMeds Brasil Featured in 'Veja' Article Highlighting Brazilian Health Authority Approval of RSHO™ on Patients with Alzheimer's Disease

Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds® Brasil was...


Feb 15, 2017, 08:30 ET Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes

Abbott (NYSE: ABT) today announced the results of real-world use data[1] showing that people who scan more frequently using Abbott′s FreeStyle®...


Feb 15, 2017, 08:00 ET Everon Biosciences Publishes a Study Suggesting a New Biomarker of Senescent Cells for Anti-Aging Research and Drug Development

Today, a research team from Everon Biosciences, Inc. and Roswell Park Cancer Institute has published a new study in Proceedings of the National...


Feb 15, 2017, 08:00 ET Bayer to Showcase Oncology Data at ASCO GU 2017

Bayer announced today that its latest research findings on Xofigo® (radium Ra 223 dichloride) injection will be presented at the 2017 Genitourinary...


Feb 15, 2017, 08:00 ET The FDA has Approved Tirosint-SOL, Levothyroxine in Liquid Solution for the American Market, IBSA Patent

IBSA announced today that the US Food and Drug Administration (FDA) has approved Tirosint-SOL (levothyroxine sodium oral solution), a liquid...


Feb 15, 2017, 08:00 ET Entest BioMedical Inc.'s Zander Therapeutics Unit Announces Publication of Canine Cellular Immunotherapy Patent Application for Treating Cancer in Dogs

Entest BioMedical Inc.'s (OTCPINK: ENTB) wholly owned subsidiary, Zander Therapeutics Inc., announced today publication by the United States...


Feb 15, 2017, 07:00 ET Bpifrance awards PathMaker Neurosystems a PIA Grant to Support Product Development

PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neuromodulation company developing non-invasive systems for the treatment of patients...


Feb 15, 2017, 06:30 ET Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease

Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage company focused on enhancing the treatment of patients with cardiorenal and gastrointestinal (GI)...


Feb 15, 2017, 06:00 ET L'FDA ha Approvato per il Mercato Americano Tirosint-SOL, Levotiroxina, Formulazione Liquida, Brevetto IBSA

Studi Clinici hanno Dimostrato che Tirosint-SOL è in Grado di Superare Alcuni Limiti Delle Compresse di Levotiroxina IBSA annuncia oggi che US...


Feb 15, 2017, 04:21 ET Biosensors annonce le recrutement du premier patient dans le nouvel essai pivot américain de BioFreedom, « LEADERS FREE II »

Biosensors International Group, Ltd. (« Biosensors » ou la « Société »), un développeur, fabricant et distributeur de dispositifs médicaux...


Feb 15, 2017, 02:00 ET Strekin AG présente les plus récentes avancées de la phase 2 du développement du STR001, ainsi que de nouvelles données précliniques sur la perte auditive

Strekin AG, entreprise bio-pharmaceutique privée en phase cliniques, a annoncé aujourd'hui la présentation de nouvelles données à l'occasion de la...


Feb 15, 2017, 02:00 ET La FDA a approuvé Tirosint-SOL (lévothyroxine en solution liquide) pour le marché américain, avec un brevet IBSA

Des études cliniques ont démontré que Tirosint-SOL peut vaincre certaines des limites inhérentes aux comprimés de lévothyroxine IBSA a...


Feb 15, 2017, 02:00 ET La FDA ha aprobado Tirosint-SOL, levotiroxina en solución líquida para el mercado americano, patente IBSA

Estudios clínicos han demostrado que Tirosint-sol podría superar algunas de las limitaciones de las tabletas de levotiroxina IBSA anunció...


Feb 15, 2017, 02:00 ET Strekin AG presenta la actualización del desarrollo en fase 2 de STR001

- Strekin AG presenta la actualización del desarrollo en fase 2 de STR001 y los nuevos datos preclínicos para pérdida auditiva...


Feb 15, 2017, 02:00 ET FDA genehmigt Tirosint-SOL, Levothyroxin in flüssiger Lösung, für den amerikanischen Markt - Patent von IBSA

Klinische Studien haben gezeigt, dass Tirosint-SOL einige der Einschränkungen von Levothyroxin-Tabletten überwinden IBSA hat heute...


Feb 15, 2017, 02:00 ET Strekin AG präsentiert aktuellen Stand der Phase-2-Entwicklung von STR001 und neue präklinische Daten zum Hörverlust

Strekin AG, ein auf klinischer Stufe aktives Biopharma-Unternehmen im Privatbesitz, gab heute bei der Konferenz der Association for Research in...